Keywords: Frontage Labs, Fanghui Pharma, CRO, Infrastructure development, Regulatory guidance, China, USA
Frontage and Fanghui Pharma launch $10 million collaboration
Article | 28 February 2012
Emerging Chinese pharmaceutical company Luohe Fanghui Pharmaceutical has launched a new globalization strategy by tapping the pharmaceutical R&D, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
